Global Positive Airway Pressure Devices Market 2016-2020
About Positive Airway Pressure Devices
Positive airway pressure (PAP) devices are used in intensive care units (ICUs), coronary care units (CCUs), operating rooms, and emergency wards of hospitals. PAP devices are pre-dosed pressure delivery systems that ensure upper airway pressure flow to keep the airways open during the treatment of obstructive sleep apnea (OSA). Congestive heart failure, sleep apnea, and chronic obstructive pulmonary disease (COPD) are the main indications for the use of PAP devices. The three types of PAP devices available in the market are CPAP, BiPAP, and APAP.
Technavio’s analysts forecast the global positive airway pressure devices market to grow at a CAGR of 8.02% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global positive airway pressure devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the devices or equipment, and accessories.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Positive Airway Pressure Devices Market 2016-2020
Technavio recognizes the following companies as the key players in the global positive airway pressure devices market: ResMed, Healthcare Philips, Fisher and Paykel Healthcare, and 3B Medical.
Other Prominent Vendors in the market are: Apex Medical, Armstrong Medical, BMC Medical, Bremed, Curative Medical, DeVilbiss Healthcare, Heyer Medical, and Genstar Technologies.
Commenting on the report, an analyst from Technavio’s team said: “Home care PAP devices are suitable for people with moderate to severe apnea. They are considered less obtrusive as they are employed in the familiar home setting of users. In addition, these devices are more in demand by people who are home-bound, aged, have chronic illnesses, and require specialized care. Also, home sleep tests are more cost-effective than lab sleep study. Therefore, this emerging trend is expected to have a positive effect on the growth of the market.”
According to the report, prevalence of sleep apnea will be a key driver for market growth. In 2014, it was estimated that sleep apnea affected over 350 million people worldwide, of which 80% were undiagnosed. Sleep apnea affects both adults and children. According to a research in 2014, around 26% of adults aged between 30 to 70 years have sleep apnea symptoms, and 16% and 10% of people across the world have mild and severe sleep apnea, respectively. Sleep apnea occurs more in men than in women (4% in men and 2% in women). Sleep apnea increases with age, and over 50% of adults 65 years and above have some form of chronic sleep-related complaints. There is also a rising incidence of sleep apnea in comorbidities globally.
Further, the report states that the high cost of treatment is a key challenge hindering the growth of the global positive airway pressure devices market. For instance, the success rate of respiratory treatments is 50% lesser than the treatment for life-threatening diseases such as breast cancer, but the treatments are twice as expensive in terms of cost per approved drug. Many individuals may not be able to afford high-cost PAP treatment without reimbursement coverage.
ResMed, Healthcare Philips, Fisher and Paykel Healthcare, 3B Medical, Apex Medical, Armstrong Medical, BMC Medical, Bremed, Curative Medical, DeVilbiss Healthcare, Heyer Medical, Genstar Technologies.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook